On 15 October 2026, BAIRONG AI-W (06608.HK) said its affiliate Shuke Youxiang will commit RMB 195m to a new fund with CICC Capital, a disclosable transaction.
On 15 October 2026, SMOORE INTL (06969.HK) repurchased 2,472,000 shares on-market under its general mandate at HKD 7.93 to 8.12 each, for HKD 19,952,300.
On 15 October 2026, BLACK SESAME (02533.HK) said certain core staff plan to buy shares with own funds by end-November 2026 for HKD 40 million to 50 million.
On 15 October 2026, AXERA (00600.HK) said its trustee bought 2,519,200 H shares under its H-share award scheme at HKD 21.17 each, for HKD 53.31 million.
On 15 October 2026, BRII-B (02137.HK) launched BRiSC, its self-developed bispecific RNAi silencing siRNA drug discovery platform for next-gen RNA therapies.
On 15 October 2026, KINWONG (03228.HK) said it completed the cancellation of 31,890 share options and plans to buy back and cancel 164,518 restricted shares.
On 15 October 2026, VOYAH AUTO (07489.HK) said the CSRC issued a filing notice for its H-share full circulation, covering 1,506,618,471 domestic shares.
On 15 October 2026, POP MART (09992.HK) granted 140,431 awards to the Group's employees at nil cost, with the shares closing at HKD 145.50 on the grant date.
On 15 October 2026, CSPC PHARMA (01093.HK) said SYS6062, a monoclonal antibody-drug conjugate, won China clinical trial approval for advanced solid tumours.
On 15 Oct 2026, XUNFEIHEALTH (02506.HK) signed a framework agreement with Rici Medical, a unit of Rici Healthcare (01526.HK), on AI model use and health data.
On 15 October 2026, CSPC PHARMA (01093.HK) said its PD-1/VEGFA/CTLA-4 trispecific antibody SYS6088 won China nod for advanced/metastatic solid tumour trials.
On 15 October 2026, DATANG ENVIRO (01272.HK) said it completed its 2026 second tranche super short-term notes of RMB 500 million at 1.37% on 14 October 2026.
On October 15, 2026, the HSTECH fell 2.72% and the HSI lost 1.03%. COSCO SHIP ENGY slid 15.64%, while southbound capital posted HK$5.08 billion of net selling.
On October 15, 2026, the HSTECH fell 2.72% and the HSI dropped 1.03%. XIAOMI-W was the only gainer in the pool, up 2.65%, while ILUVATAR COREX fell 13.64%.
On October 15, 2026, the Hong Kong ETF market saw an extreme divergence. On the upside, India-themed products dominated, with Xtrackers Nifty 50 Swap UCITS ETF (3015.HK) up 2.24% at the top of the gainers list, and four India-related ETFs occupying the top four gain slots; baijiu liquor and healthcare themes posted modest gains. On the downside, Korea and semiconductor themes fell sharply, with Xtrackers MSCI Korea UCITS ETF (2848.HK) down 9.23% as the largest decliner; all of the top ten decliners fell by at least 7.2%, of which four were Korea equity-related and four were semiconductor-related. Among southbound Stock Connect ETFs, every product declined and all were technology-themed, led by CSOP FTSE HK-Korea Tech+ Index ETF (3431.HK) at -5.97%.
On October 15, 2026, the three major Hong Kong indices moved down in a choppy range, with the Hang Seng Index down 1.03%, the Hang Seng TECH Index down 2.72%, and the Hang Seng China Enterprises Index down 0.98%.
